Defining a Role for Immunotherapy in mCRPC

]]>(MedPage Today) -- A small clinical study of checkpoint inhibitors for metastatic castration-resistant prostate cancer (mCRPC) identified favorable and unfavorable subgroups that might help inform use of the drugs in a disease that generally has...